Last reviewed · How we verify
Investigational H9N2 vaccine GSK2654911A — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Investigational H9N2 vaccine GSK2654911A (Investigational H9N2 vaccine GSK2654911A) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Investigational H9N2 vaccine GSK2654911A TARGET | Investigational H9N2 vaccine GSK2654911A | GlaxoSmithKline | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Investigational H9N2 vaccine GSK2654911A CI watch — RSS
- Investigational H9N2 vaccine GSK2654911A CI watch — Atom
- Investigational H9N2 vaccine GSK2654911A CI watch — JSON
- Investigational H9N2 vaccine GSK2654911A alone — RSS
Cite this brief
Drug Landscape (2026). Investigational H9N2 vaccine GSK2654911A — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-h9n2-vaccine-gsk2654911a. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab